Bristol-Myers Squibb

The Axe Falls: Bristol-Myers To Cut Nearly 500 Jobs
Pharmalot
Tue, 11/6/12 - 12:08 pm
layoffs
Bristol-Myers Squibb
How Does The Patent Exclusivity Factor Affect The 3 Top Dividend-Paying Healthcare Companies?
Seeking Alpha
Fri, 11/2/12 - 10:26 am
patents
Amarin
AstraZeneca
Bristol-Myers Squibb
GSK
Bristol-Myers Squibb: Investors Can Focus On The Future After Plavix
Seeking Alpha
Mon, 10/29/12 - 10:35 am
Plavix
generics
Bristol-Myers Squibb
Bristol-Myers Squibb and Eli Lilly: The Patent Cliff Strikes Back
Wall Street Cheat Street
Sat, 10/27/12 - 12:19 pm
Bristol-Myers Squibb
Eli Lilly
Bristol-Myers results lag as Plavix sales evaporate
Reuters
Wed, 10/24/12 - 11:00 am
Bristol-Myers Squibb
earnings
3 Diabetes Phase 3 Wins
Motley Fool
Tue, 10/23/12 - 04:19 pm
Merck
Sanofi
Eli Lilly
diabetes
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Amylin
Bristol-Myers Squibb Earnings Up Next
Motley Fool
Mon, 10/22/12 - 11:30 am
Bristol-Myers Squibb
earnings
Bristol-Myers Squibb Third Quarter Earnings Preview
Investopedia.com
Fri, 10/19/12 - 11:33 am
earnings
Bristol-Myers Squibb
Bristol-Myers Trails U.S. Rivals as Promising Drugs Fade
Bloomberg
Mon, 10/15/12 - 11:38 am
Bristol-Myers Squibb
5 Top Pharmaceuticals Paying Substantial Dividends
Seeking Alpha
Sun, 10/14/12 - 11:19 am
Bristol-Myers Squibb
JNJ
Eli Lilly
Pfizer
Merck
Our Fourth Nominee for Worst CEO of the Year: Lamberto Andreotti
Motley Fool
Sun, 10/14/12 - 10:57 am
Bristol-Myers Squibb
Lamberto Andreotti
Is a VIVUS Buyout Still on the Table? And if So, by Whom?
Motley Fool
Fri, 10/12/12 - 11:02 am
Vivus
M&A
Bristol-Myers Squibb
Merck
JNJ
Arena Pharmaceuticals
Bristol Myers' Competition Causes Increased Risk
Seeking Alpha
Thu, 10/11/12 - 11:39 am
Bristol-Myers Squibb
Pfizer
Sanofi
Eli Lilly
AstraZeneca
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Idenix: Is This Hepatitis-C Company a Bargain or a Bust?
Motley Fool
Wed, 10/10/12 - 12:39 pm
Idenix
hepatitis C
BMS-986094
Bristol-Myers Squibb
Life Technologies Continues Acquisition Spree
Yahoo/Zacks.com
Tue, 10/9/12 - 04:13 pm
M&A
Life Technologies
Compendia Bioscience
Bristol-Myers Squibb
GSK
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Seeking Alpha
Tue, 10/9/12 - 09:55 am
obesity
Novo Nordisk
Merck
Bristol-Myers Squibb
diabetes
Sanofi
This Big Pharma Pair Parts Ways
Motley Fool
Sat, 10/6/12 - 11:42 am
Bristol-Myers Squibb
Sanofi
Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up
Bloomberg
Fri, 10/5/12 - 11:25 am
Bristol-Myers Squibb
Novo Nordisk
Amylin
diabetes
This Big Pharma Pair Parts Ways
Motley Fool
Fri, 10/5/12 - 11:19 am
Sanofi
Bristol-Myers Squibb

Pages